Elekta´s opponent in U.S. patent dispute denied reconsideration

ELEKTA'S OPPONENT IN U.S. PATENT DISPUTE DENIED RECONSIDERATION On Thursday October 30, 2003, the United States Court of Appeals for the Federal Circuit announced its decision to deny the petition from Medical Instrumentation and Diagnostics Corporation (Midco), Elekta's opponent in the U.S. patent dispute, to reconsider its ruling issued on September 22, 2003. As a result the ruling by the court, which among other findings determined that none of Elekta's products infringed the Midco patents and in which Elekta was freed from all liability, remains valid. Midco may file a petition for review (certiorari) with the United States Supreme Court. Grant of this remedy is very unusual. The full opinion of the court from September 22 is available at www.fedcir.gov/dailylog.html, docket no. 03-1032. *********** For further information, please contact: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ), Phone: +46 8 587 254 00, e-mail: peter.ejemyr@elekta.com Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient. For additional information about Elekta, please visit www.elekta.com ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/10/31/20031031BIT00040/wkr0001.doc http://www.waymaker.net/bitonline/2003/10/31/20031031BIT00040/wkr0002.pdf

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe